Tonight: Thriving without regulation. A look at innovative companies and industries that are challenging the status quo.

Tonight: Are Americans ready for the holiday shopping season? New economic data sheds light on the health of the consumer.

Tonight: Tensions are running high across the globe. We’ll take a look at the potential market impact.

Tonight: Pfizer and Allergan are combining in a $160 billion deal, handing Pfizer a new address and creating a lot of controversy.

Tonight: The S&P 500 has its best week of the year. We’ll explore if the rally can continue and where you should put your money now

Tonight: UnitedHealthcare surprises Wall Street and Main Street when saying it may leave the public health exchanges.

Tonight: The Federal Reserve sends its clearest signal yet that a December rate hike is likely.

Tonight: The markets show their fragility as the manhunt for suspects in the Paris attacks continues.

Tonight: How stocks across the globe reacted to the terror attacks in Paris.

Tonight: Stocks suffer their biggest weekly loss in nearly three months and it’s not just equities that are seeing sharp declines. Our market monitor has some advice on how to invest in this uncertain market.

Tonight: A slowdown in orders overshadows better-than-expected results from Dow component Cisco.

Tonight: Macy’s, a retail industry bellwether, disappoints investors right before the very important holiday season. Will the rest of the sector follow suit?

Tonight: Criminal charges are filed in one of the biggest bank breaches ever.

Tonight: Stocks fall sharply as investors adjust to the new reality that higher rates are on the way.

Tonight: The jobs number crushes economists’ estimates. But, does a blowout number automatically mean the Federal Reserve will raise interest rates next month?